Akers Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AKER and buy or sell other stocks, ETFs, and their options commission-free!About AKER
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms.
CEOChristopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees—
Employees—
HeadquartersBaltimore, Maryland
HeadquartersBaltimore, Maryland
Founded1989
Founded1989
Employees—
Employees—
AKER Key Statistics
Market cap97.49M
Market cap97.49M
Price-Earnings ratio-6.65
Price-Earnings ratio-6.65
Dividend yield—
Dividend yield—
Average volume557.91K
Average volume557.91K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.15
52 Week high$6.15
52 Week low$0.90
52 Week low$0.90
Stock Snapshot
With a market cap of 97.49M, Akers Biosciences(AKER) trades at $2.47. The stock has a price-to-earnings ratio of -6.65.
During the trading day, Akers Biosciences(AKER) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Akers Biosciences(AKER) stock has reached 0, versus its average volume of 557.91K.
Over the past 52 weeks, Akers Biosciences(AKER) stock has traded between a high of $6.15 and a low of $0.90.
Over the past 52 weeks, Akers Biosciences(AKER) stock has traded between a high of $6.15 and a low of $0.90.